ReviewFrontiers in cell and developmental biology2020

Pros and Cons of Denosumab Treatment for Osteoporosis and Implication for RANKL Aptamer Therapy.

Ning Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.